Boiled urinary extracts, which had inhibited the activity of human chorionic gonadotrophin (HCG) (Futterweit et al. 1963) and in the ovarian ascorbic acid depletion (OAAD) assay (Ota et al. 1967) . Results in the mouse uterus assay were confirmed using boiled kaolin-acetone and tannic acid extracts of urine (Hipkin 1968a,¿ 
A boiled kaolin-alcohol extract of urine inhibited the activity of human chorionic gonadotrophin (HCG) in the immature mouse and rat uterine weight assays (Futlerweit et al. 1963; Soffer et al. 1966) . The presence of an HCG or lutenising hormone (LH) antagonist in urine was supported by the observa¬ tion that LH activity was also suppressed by urinary extracts in the ventral prostate weight assay (VPW) in intact and hypophysectomised animals (Futterweit et al. 1963) and in the ovarian ascorbic acid depletion (OAAD) assay (Ota et al. 1967) . Results in the mouse uterus assay were confirmed using boiled kaolin-acetone and tannic acid extracts of urine (Hipkin 1968a,¿) . On the other hand, these extracts potentiated responses to HCG in the rat uterus assay (Hipkin 1970) . It was concluded that the urinary extracts were toxic and that the experimental animals responded to the stress of the injection by an alteration in endogenous gonadotrophin secretion. In view of the nonspecificity of uterine weight assays, the present report is concerned with the effects of urinary extracts in specific assays for HCG and follicle-stimulating hormone (FSH) , namely the OAAD, the VPW and the rat ovarian augmen¬ tation (OA) 
Materials
Pregnant mares' serum gonadotrophin (PMS) and HCG were supplied by Organon Laboratories (Gestyl® and Pregnyl® respectively).
Pooled urine from non-pregnant women and from male patients was extracted by the kaolin-acetone procedure of Loraine Se Brown (1959) . The extracts were suspended in saline (pH = 6) and boiled for 1 hour under reflux to destroy gonadotrophic ac¬ tivity. Fifty ml urine equivalents of the boiled extract was inactive in the mouse uterus assay.
Experimental procedure
The OAAD test was performed exactly as described by Bell et al. (1965) . Each animal was primed with 50 IU PMS followed 72 h later by 25 IU HCG. Both gonadotrophins were administered subcutaneously in 0.5 ml distilled water. Six days after the priming dose of HCG, the rats were divided into three groups containing eight animals. These were injected intraperitoneally with either 0.5 ml saline, 0.5 IU HCG or 1.5 IU HCG (both doses in 0.5 ml saline). Half the animals in each group were then given an intraperitoneal injection of 0.5 ml saline while the remainder were similarly treated with the boiled urinary extract, in a dose equivalent to 100 ml urine. The intraperitoneal administration of the test materials was preferred because of the toxic nature of the urinary extract. Even by this route, increasing the dose to 200 ml urine equivalents was associated with the death of some animals. The re¬ mainder of the procedure was that used by Bell et al. (1965) . The results were statis¬ tically analysed by the method of Gaddum (1953 (Johnsen 1958) 
The VPW method was performed as described by Christiansen (1967 Each dose of FSH was mixed with 20 IU HCG (Physex®, Leo) in a total volume of 3 ml.
The urinary material was extracted from the urine of male and non-pregnant female patients by the kaolin-acetone method of Borth et al. (1961) . The extracts were pooled, suspended in distilled water and boiled at pH 6 as before. A total dose of 800 ml urine equivalents was used for each animal. The uterine weight method of Johnsen (1958) failed to detect gonadotrophins in the boiled extract (< 3 MUU/1).
The rat ovarian augmentation assay was performed as described by Christiansen (in press). FSH was administered subcutaneously (0.5 ml), one injection being given on days 1 and 4 and two on days 2 and 3. Some groups of animals were only treated with 20 IU HCG. The boiled extract was also given daily (0.2 ml) at the same time as the first or only injection of FSH but at a different subcutaneous site. In hypo¬ physectomised animals, treatment was started immediately after the operation. In this series, cortisone was necessary as for the VPW experiments. On the 5th day the animals were killed and weighed, and the paired ovarian weight obtained. The sella turcica from operated animals was examined and results from the groups were com¬ pared as in the VPW assay.
RESULTS
The effect of the boiled urinary extract on the depletion of ovarian ascorbic acid in response to HCG is shown in Fig. 1 Johnsen (1958) extract (48 h urine equivalent/rat) in the VPW assay in intact rats is shown in Fig. 2 (Fig. 3) . There was no significant difference in mean final body weight between buffer and extract treated animals in either the intact (49.2 ± 2.6 g and 48.5 ± 1.9 g respectively) or hypophysectomised groups (38.1 ± 1.7 g and 35.1 ± 0.9 g respectively). How¬ ever, the material was toxic judged by the significantly higher (P < 0.001) adrenal weight resulting from injections of extract into intact animals. The mean weight of both glands in those given buffer was 12.3 ± 0.5 mg compared with 15.5 ± 0.5 mg for those treated with urinary material. The completeness of hypophysectomy, at least in the buffer group was supported by a mean adrenal weight of 5.5 ± 0.2 mg. (Hipkin 1968a,b) while responses in the rat uterus assay were augmented (Hipkin 1970 (pH 8.9 ) by heating at 80°C for 1 hour. Boiling for 1 hour is also recommended for the preparation of the urinary gonadotrophin inhibitor from urinary gonadotrophic extracts (Futterweit et al. 1963 ). In the present study care was taken that HCG from pregnancy urine did not contaminate the extracts. Furthermore, two of the boiled extracts were devoid of gonadotrophic activity when tested in the mouse uterus assay, while the third was inactive in the VPW assay.
Although different extracts and different doses have been employed in the above studies, they have had in common a toxic effect on the experimental animals used. In the uterine weight assays (Hipkin 1968«, 1970 Johnsen (1958) extract has no adrenal weight stimulating activity in hypophysectomised animals (Christiansen, per¬ sonal communication) . It is the toxicity of the various urinary extracts which is thought to be responsible for their gonadotrophin-inhibitory activity in the mouse uterus assay (Hipkin 1969a (Hipkin 1969&, 1970 (McArthur et al. 19676 ). However, presumably the same dose of extract inhibiting growth in intact rats will also inhibit gonadotrophin respon¬ ses in hypophysectomized animals. These factors may account for some of the differences between assays in the effects of toxic extracts in this and other investigations.
Ovarian ascorbic acid depletion assay
In the rat uterus assay, the boiled urinary extract stimulated some uterine growth when given alone, and for this reason it potentiated HCG activity in this assay (Hipkin 1970 ). An identical situation exists in the OAAD assay reported here since the extract itself produced significant ovarian ascorbic acid depletion. As pointed out earlier, it is most unlikely that the ovarian ascorbic acid depletion results from residual gonadotrophin in the boiled extract. Even if 10°/o of the activity remained, it is improbable that the response obtained with 100 ml urine equivalents of heated extract would be reproduced by 10 ml equivalents of unboiled extract containing only pituitary gonadotrophin. Fur-thermore, 200 ml urine equivalents of boiled extract produced the same per¬ centage fall in ovarian ascorbic acid concentration as did 100 ml equivalents. In any case, the results of the present investigation support the finding of Koed Sc Hamburger (1968) . They noted that urinary extracts from children and hypophysectomised patients produced a significant response in the OAAD assay, although proven to be devoid of gonadotrophic activity by other me¬ thods. The authors concluded that inert urinary proteins deplete ovarian ascorbic acid non-specifically and that the effect was similar to that produced by a heterogeneous group of substances reviewed by Gibson et al. (1965) . Of the materials listed, it is interesting to note that adrenaline and serotonin (Hipkin 1969 ) , pitressin (Hipkin 1969a) , arginine vasotocin (Pavel Sc Petrescu 1966) and propylene glycol (unpublished observations) all inhibit gonado¬ trophic activity in the mouse uterus assay.
Although it is possible that the ovarian ascorbic acid depleting activity of the urinary extract results from a direct toxic effect on the ovary, a more likely explanation is that it causes secretion of endogenous luteinising hormone as part of a stress reaction. This hypothesis is based on the similarity between the results obtained in this investigation and those from the rat uterus assay (Hipkin 1970) . Apart from the toxic urinary extract, such stressing procedures as starvation and carbon tetrachloride injection also stimulated uterine growth in the rat. Stressful procedures cause non-specific inhibition of HCG activity in the mouse uterus assay (Hipkin 1969&) . This would explain why the mate¬ rials listed above produce different effects depending on whether the mouse uterus assay or OAAD assay is used. The effect of the toxic extract on the rat uterus assay was studied using intact and hypophysectomised animals (Hipkin 1970 Even the standard, the second IRP-HMG, is toxic and produces a flat doseresponse curve at certain dose levels (Rosemberg 1967) . These results can be explained on the basis of a non-specific release of endogenous LH. If the toxic effects of the urinary extracts can be reduced by altering the route of ad¬ ministration, then this should improve the OAAD assay. This is the basis of a modified test described by Mondina Sc Polvani (1970) .
The demonstration of a urinary gonadotrophin inhibitor reported by Ota et al. (1967) (Hipkin 1970) . In fact, the dose chosen for the present investigation was double that used in the earlier study because in the VPW assay, 6 rather than 3 daily injections are given. As pointed out earlier, this dose was toxic judged by the adrenal weight stimula¬ tion in the test animals. The most likely explanation for the failure of the extract to augment HCG activity is that the VPW assay is relatively insen¬ sitive. In the uterine weight assay a dose of 0.2 IU HCG produced a sig¬ nificant response (Hipkin 1970) , while in the VPW method a dose between 0.4 and 0.8 IU is necessary (Fig. 2) (Fig. 4) .
In addition to the enhanced endogenous LH secretion produced by toxic extracts referred to earlier, the results in the OA assay suggest that endo¬ genous FSH secretion is also increased (Fig. 4) . The augmentation of HCG activity by stressful procedures in the rat uterine weight assay (Hipkin 1970) is therefore due to the secretion of both gonadotrophins. The effect of the toxic urinary extract in the present investigation differs from the findings of McArthur et al. (1967a,b) . Using the Steelman Sc Pohley (1953) assay, they noted that extracts inhibited the FSH activity of menopausal gonadotrophin if they were sufficiently toxic to interfere with normal body weight gain. A similar conclusion was reached when the ovarian aug¬ mentation assay was conducted in mice (Hipkin 1969a (Stevens 1967 ).
